Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.22.2.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 37 $ 576
Restricted cash 112 374
Deferred course expenses 260 304
Prepaid expenses and other current assets 330 607
Inventory 1 1
Discontinued operations current assets
Total current assets 740 1,862
Right-of-use assets 20
Other assets 6 6
Discontinued operations-other assets 32 33
Total assets 778 1,921
Current liabilities:    
Accounts payable 2,553 2,544
Royalties payable 110 110
Accrued course expenses 236 252
Accrued salaries, wages and benefits 192 202
Operating lease liability, current portion 20
Other accrued expenses 775 2,114
Deferred revenue 4,114 4,438
Short-term related party debt, net of unamortized debt discount of $133 1,178 142
Current portion of long term debt, net of unamortized debt discount of $0 344 1,011
Discontinued operations-current liabilities 10,651 9,845
Total current liabilities 20,153 20,678
Long-term debt, net of current portion and net of unamortized debt discount 1,740 1,933
Deferred tax liability, net 1,336 1,493
Other long term liabilities
Operating lease liability, net of current portion
Total liabilities 23,229 24,104
Stockholders’ deficit:    
Preferred stock, $0.0001 par value, 20,000,000 shares authorized, none issued
Common stock, $0.0001 par value; 200,000,000 authorized; 37,867,697and 33,917,697 shares issued and outstanding as of September 30, 2022, and December 31, 2021 3 3
Additional paid-in capital 13,225 13,161
Cumulative foreign currency translation adjustment 1,559 837
Accumulated deficit (37,238) (36,184)
Total stockholders’ deficit (22,451) (22,183)
Total liabilities and stockholders’ deficit $ 778 $ 1,921